Widya is the Chief Business Officer and founding team member of Venn Biosciences, a San Francisco-based life science company combining epiproteomics, artificial intelligence, and epidemiology to develop liquid biopsy tests for cancer diagnosis. Widya was previously the Director of New Ventures at Johnson & Johnson Innovation, overseeing partnership deals across medical device and pharmaceutical sectors on the US West Coast. Widya came to J&J from McKinsey & Company, where she was a management consultant advising clients in healthcare and other industries on corporate strategy, lean operations, and organizational health topics. Prior to McKinsey, Widya worked at GE Ventures Healthcare and co-founded a medical device startup, where she served as Chief Scientist developing biodegradable wound closure devices. Widya received her B.S. in Materials Science and Bioengineering from the University of California Berkeley and her Ph.D. in Bioengineering from Stanford University where she was a Siebel Scholar.